• Ticker

DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

Sparton Corp

NYSE:SPA

$8.88 $0.04 (0.45%)

REAL-TIME: Last trade at

Isis Loss Widens on Higher Expenses - Analyst Blog

Stoneridge Beats, Profits Up - Analyst Blog

FDA Panel to Review Onyx Drug - Analyst Blog

Isis Loss Widens; Focus on Kynamro - Analyst Blog

Onyx Pharma's MM Candidate Advances - Analyst Blog

Maxwell Gets Swiss Funding - Analyst Blog

Amiket, Another Key Value Driver for EpiCept - Analyst Blog

Galena Biopharma Initiates Phase III PRESENT Trial Of NeuVax Ahead of Schedule - Analyst Blog

Onyx' Cancer Drug on Right Track - Analyst Blog

Sparton Corporation's CEO Discusses Q1 2011 Results - Earnings Call Transcript

Sparton Corporation's CEO Discusses Q1 2011 Results - Q&A Transcript

Sparton Corporation CEO Discusses F2Q2011 Results - Earnings Call Question and Answer Session Transc

Sparton Corporation CEO Discusses F2Q2011 Results - Earnings Call Question and Answer Session Transc

13 Above Average Stocks: Industry Leaders or Boat Anchors in Disguise?

Sparton CEO Discusses F1Q2011 Results - Earnings Call Transcript

Sparton CEO Discusses F1Q2011 Results - Earnings Call Transcript

Sparton: Turnaround Team Returns Micro-Cap Manufacturer to Profitability

Sparton: Delphi Medical Acquisition Should Be Highly Accretive

Sparton CEO Discusses F4Q2010 Results - Earnings Call Transcript

Sparton CEO Discusses F4Q2010 Results - Earnings Call Question and Answer Session Transcript

Sparton CEO Discusses F4Q2010 Results - Earnings Call Question and Answer Session Transcript

Sparton: Delphi Medical Acquisition Should Be Highly Accretive

Sparton: An Undiscovered Turnaround